{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T02:29:43Z","timestamp":1785292183042,"version":"3.55.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CORPG3P0281, CORPG3P0291, CMRPG3K1093, CORPG3P0021, CORPG3N0011"],"award-info":[{"award-number":["CORPG3P0281, CORPG3P0291, CMRPG3K1093, CORPG3P0021, CORPG3N0011"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPD1N0401, BMRP488"],"award-info":[{"award-number":["CMRPD1N0401, BMRP488"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 113-2314-B-182-042-MY2"],"award-info":[{"award-number":["NSTC 113-2314-B-182-042-MY2"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00259-025-07539-x","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T06:53:48Z","timestamp":1759301628000},"page":"1991-2003","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Visual interpretation of [18F]Florzolotau Tau-PET imaging for differentiating alzheimer\u2019s disease and progressive supranuclear palsy"],"prefix":"10.1007","volume":"53","author":[{"given":"Huan-Chun","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Lun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Hsin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsung-Ying","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin-Chang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Lung","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiung-Chih","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun-Ju","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5255-7498","authenticated-orcid":false,"given":"Ing-Tsung","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,1]]},"reference":[{"key":"7539_CR1","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/BF00688336","volume":"74","author":"C Bancher","year":"1987","unstructured":"Bancher C, Lassmann H, Budka H, Grundke-Iqbal I, Iqbal K, Wiche G, et al. Neurofibrillary tangles in Alzheimer\u2019s disease and progressive supranuclear palsy: antigenic similarities and differences. Microtubule-associated protein Tau antigenicity is prominent in all types of tangles. Acta Neuropathol. 1987;74:39\u201346. https:\/\/doi.org\/10.1007\/BF00688336.","journal-title":"Acta Neuropathol"},{"key":"7539_CR2","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/BF00296367","volume":"81","author":"S Flament","year":"1991","unstructured":"Flament S, Delacourte A, Verny M, Hauw JJ, Javoy-Agid F. Abnormal tau proteins in progressive supranuclear palsy. Similarities and differences with the neurofibrillary degeneration of the alzheimer type. Acta Neuropathol. 1991;81:591\u20136. https:\/\/doi.org\/10.1007\/BF00296367.","journal-title":"Acta Neuropathol"},{"key":"7539_CR3","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","volume":"7","author":"RA Sperling","year":"2011","unstructured":"Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, et al. Toward defining the preclinical stages of Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7:280\u201392. https:\/\/doi.org\/10.1016\/j.jalz.2011.03.003.","journal-title":"Alzheimers Dement"},{"key":"7539_CR4","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/S1474-4422(09)70042-0","volume":"8","author":"DR Williams","year":"2009","unstructured":"Williams DR, Lees AJ. Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges. Lancet Neurol. 2009;8:270\u20139. https:\/\/doi.org\/10.1016\/S1474-4422(09)70042-0.","journal-title":"Lancet Neurol"},{"key":"7539_CR5","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.parkreldis.2011.02.017","volume":"17","author":"VG Evidente","year":"2011","unstructured":"Evidente VG, Adler CH, Sabbagh MN, Connor DJ, Hentz JG, Caviness JN, et al. Neuropathological findings of PSP in the elderly without clinical PSP: possible incidental PSP? Parkinsonism Relat Disord. 2011;17:365\u201371. https:\/\/doi.org\/10.1016\/j.parkreldis.2011.02.017.","journal-title":"Parkinsonism Relat Disord"},{"key":"7539_CR6","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/S1474-4422(17)30157-6","volume":"16","author":"AL Boxer","year":"2017","unstructured":"Boxer AL, Yu JT, Golbe LI, Litvan I, Lang AE, Hoglinger GU. Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches. Lancet Neurol. 2017;16:552\u201363. https:\/\/doi.org\/10.1016\/S1474-4422(17)30157-6.","journal-title":"Lancet Neurol"},{"key":"7539_CR7","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/mds.26987","volume":"32","author":"GU Hoglinger","year":"2017","unstructured":"Hoglinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE, et al. Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov Disord. 2017;32:853\u201364. https:\/\/doi.org\/10.1002\/mds.26987.","journal-title":"Mov Disord"},{"key":"7539_CR8","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/s00234-019-02188-y","volume":"61","author":"MW Vernooij","year":"2019","unstructured":"Vernooij MW, Pizzini FB, Schmidt R, Smits M, Yousry TA, Bargallo N, et al. Dementia imaging in clinical practice: a European-wide survey of 193 centres and conclusions by the ESNR working group. Neuroradiology. 2019;61:633\u201342. https:\/\/doi.org\/10.1007\/s00234-019-02188-y.","journal-title":"Neuroradiology"},{"key":"7539_CR9","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s40336-018-0290-y","volume":"6","author":"N Okamura","year":"2018","unstructured":"Okamura N, Harada R, Ishiki A, Kikuchi A, Nakamura T, Kudo Y. The development and validation of tau PET tracers: current status and future directions. Clin Transl Imaging. 2018;6:305\u201316. https:\/\/doi.org\/10.1007\/s40336-018-0290-y.","journal-title":"Clin Transl Imaging"},{"key":"7539_CR10","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.2967\/jnumed.114.139550","volume":"55","author":"H Hashimoto","year":"2014","unstructured":"Hashimoto H, Kawamura K, Igarashi N, Takei M, Fujishiro T, Aihara Y, et al. Radiosynthesis, photoisomerization, biodistribution, and metabolite analysis of 11 C-PBB3 as a clinically useful PET probe for imaging of Tau pathology. J Nucl Med. 2014;55:1532\u20138. https:\/\/doi.org\/10.2967\/jnumed.114.139550.","journal-title":"J Nucl Med"},{"key":"7539_CR11","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1007\/s00259-015-3035-4","volume":"42","author":"R Harada","year":"2015","unstructured":"Harada R, Okamura N, Furumoto S, Furukawa K, Ishiki A, Tomita N, et al. [(18)F]THK-5117 PET for assessing neurofibrillary pathology in alzheimer\u2019s disease. Eur J Nucl Med Mol Imaging. 2015;42:1052\u201361. https:\/\/doi.org\/10.1007\/s00259-015-3035-4.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7539_CR12","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.apradiso.2017.10.002","volume":"130","author":"TJ Betthauser","year":"2017","unstructured":"Betthauser TJ, Ellison PA, Murali D, Lao PJ, Barnhart TE, Furumoto S, et al. Characterization of the radiosynthesis and purification of [(18)F]THK-5351, a PET ligand for neurofibrillary Tau. Appl Radiat Isot. 2017;130:230\u20137. https:\/\/doi.org\/10.1016\/j.apradiso.2017.10.002.","journal-title":"Appl Radiat Isot"},{"key":"7539_CR13","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.2967\/jnumed.116.189126","volume":"58","author":"IT Hsiao","year":"2017","unstructured":"Hsiao IT, Lin KJ, Huang KL, Huang CC, Chen HS, Wey SP, et al. Biodistribution and radiation dosimetry for the tau tracer (18)F-THK-5351 in healthy human subjects. J Nucl Med. 2017;58:1498\u2013503. https:\/\/doi.org\/10.2967\/jnumed.116.189126.","journal-title":"J Nucl Med"},{"key":"7539_CR14","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.nucmedbio.2016.12.004","volume":"46","author":"V Stepanov","year":"2017","unstructured":"Stepanov V, Svedberg M, Jia Z, Krasikova R, Lemoine L, Okamura N, et al. Development of [(11)C]\/[(3)H]THK-5351 - A potential novel carbon-11 Tau imaging PET radioligand. Nucl Med Biol. 2017;46:50\u20133. https:\/\/doi.org\/10.1016\/j.nucmedbio.2016.12.004.","journal-title":"Nucl Med Biol"},{"key":"7539_CR15","doi-asserted-by":"publisher","first-page":"4778","DOI":"10.1021\/acs.jmedchem.6b00166","volume":"59","author":"AM Walji","year":"2016","unstructured":"Walji AM, Hostetler ED, Selnick H, Zeng Z, Miller P, Bennacef I, et al. Discovery of 6-(Fluoro-(18)F)-3-(1H-pyrrolo[2,3-c]pyridin-1-yl)isoquinolin-5-amine ([(18)F]-MK-6240): A positron emission tomography (PET) imaging agent for quantification of neurofibrillary tangles (NFTs). J Med Chem. 2016;59:4778\u201389. https:\/\/doi.org\/10.1021\/acs.jmedchem.6b00166.","journal-title":"J Med Chem"},{"key":"7539_CR16","doi-asserted-by":"publisher","first-page":"975","DOI":"10.2967\/jnumed.116.185199","volume":"58","author":"L Declercq","year":"2017","unstructured":"Declercq L, Rombouts F, Koole M, Fierens K, Marien J, Langlois X, et al. Preclinical evaluation of (18)F-JNJ64349311, a novel PET tracer for tau imaging. J Nucl Med. 2017;58:975\u201381. https:\/\/doi.org\/10.2967\/jnumed.116.185199.","journal-title":"J Nucl Med"},{"key":"7539_CR17","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1097\/RLU.0000000000003164","volume":"45","author":"JL Hsu","year":"2020","unstructured":"Hsu JL, Lin KJ, Hsiao IT, Huang KL, Liu CH, Wu HC, et al. The imaging features and clinical associations of a novel Tau PET tracer-18F-APN1607 in alzheimer disease. Clin Nucl Med. 2020;45:747\u201356. https:\/\/doi.org\/10.1097\/RLU.0000000000003164.","journal-title":"Clin Nucl Med"},{"key":"7539_CR18","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3233\/JAD-200287","volume":"76","author":"Y Su","year":"2020","unstructured":"Su Y, Fu J, Yu J, Zhao Q, Guan Y, Zuo C, et al. Tau PET imaging with [18F]PM-PBB3 in frontotemporal dementia with MAPT mutation. J Alzheimers Dis. 2020;76:149\u201357. https:\/\/doi.org\/10.3233\/JAD-200287.","journal-title":"J Alzheimers Dis"},{"key":"7539_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.00604","volume":"14","author":"J Lu","year":"2020","unstructured":"Lu J, Bao W, Li M, Li L, Zhang Z, Alberts I, et al. Associations of [(18)F]-APN-1607 tau PET binding in the brain of Alzheimer\u2019s disease patients with cognition and glucose metabolism. Front Neurosci. 2020;14: 604. https:\/\/doi.org\/10.3389\/fnins.2020.00604.","journal-title":"Front Neurosci"},{"key":"7539_CR20","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.neuron.2020.09.042","volume":"109","author":"K Tagai","year":"2021","unstructured":"Tagai K, Ono M, Kubota M, Kitamura S, Takahata K, Seki C, et al. High-Contrast in vivo imaging of Tau pathologies in alzheimer\u2019s and Non-Alzheimer\u2019s disease tauopathies. Neuron. 2021;109:42\u2013e588. https:\/\/doi.org\/10.1016\/j.neuron.2020.09.042.","journal-title":"Neuron"},{"key":"7539_CR21","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1001\/jama.2018.12917","volume":"320","author":"R Ossenkoppele","year":"2018","unstructured":"Ossenkoppele R, Rabinovici GD, Smith R, Cho H, Scholl M, Strandberg O, et al. Discriminative accuracy of [18F]flortaucipir positron emission tomography for alzheimer disease vs other neurodegenerative disorders. JAMA. 2018;320:1151\u201362. https:\/\/doi.org\/10.1001\/jama.2018.12917.","journal-title":"JAMA"},{"key":"7539_CR22","doi-asserted-by":"publisher","first-page":"911","DOI":"10.2967\/jnumed.119.236224","volume":"61","author":"A Mueller","year":"2020","unstructured":"Mueller A, Bullich S, Barret O, Madonia J, Berndt M, Papin C, et al. Tau PET imaging with (18)F-PI-2620 in patients with alzheimer disease and healthy controls: a first-in-humans study. J Nucl Med. 2020;61:911\u20139. https:\/\/doi.org\/10.2967\/jnumed.119.236224.","journal-title":"J Nucl Med"},{"key":"7539_CR23","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.neurobiolaging.2018.08.022","volume":"72","author":"SA Schultz","year":"2018","unstructured":"Schultz SA, Gordon BA, Mishra S, Su Y, Perrin RJ, Cairns NJ, et al. Widespread distribution of tauopathy in preclinical Alzheimer\u2019s disease. Neurobiol Aging. 2018;72:177\u201385. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2018.08.022.","journal-title":"Neurobiol Aging"},{"key":"7539_CR24","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13024-021-00476-x","volume":"16","author":"DC Chung","year":"2021","unstructured":"Chung DC, Roemer S, Petrucelli L, Dickson DW. Cellular and pathological heterogeneity of primary tauopathies. Mol Neurodegener. 2021;16:57. https:\/\/doi.org\/10.1186\/s13024-021-00476-x.","journal-title":"Mol Neurodegener"},{"issue":"1","key":"7539_CR25","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1002\/mds.26844","volume":"32","author":"H Cho","year":"2017","unstructured":"Cho H, Choi JY, Hwang MS, Lee SH, Ryu YH, Lee MS, et al. Subcortical (18)F-AV-1451 binding patterns in progressive supranuclear palsy. Mov Disord. 2017;32(1):134\u201340. https:\/\/doi.org\/10.1002\/mds.26844.","journal-title":"Mov Disord"},{"key":"7539_CR26","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1002\/mds.28672","volume":"36","author":"L Li","year":"2021","unstructured":"Li L, Liu FT, Li M, Lu JY, Sun YM, Liang X, et al. Clinical utility of (18)F-APN-1607 tau PET imaging in patients with progressive supranuclear palsy. Mov Disord. 2021;36:2314\u201323. https:\/\/doi.org\/10.1002\/mds.28672.","journal-title":"Mov Disord"},{"key":"7539_CR27","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1007\/s00259-022-06104-0","volume":"50","author":"FT Liu","year":"2023","unstructured":"Liu FT, Lu JY, Li XY, Liang XN, Jiao FY, Ge JJ, et al. (18)F-Florzolotau PET imaging captures the distribution patterns and regional vulnerability of tau pathology in progressive supranuclear palsy. Eur J Nucl Med Mol Imaging. 2023;50:1395\u2013405. https:\/\/doi.org\/10.1007\/s00259-022-06104-0.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7539_CR28","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1093\/brain\/aww340","volume":"140","author":"L Passamonti","year":"2017","unstructured":"Passamonti L, Vazquez Rodriguez P, Hong YT, Allinson KS, Williamson D, Borchert RJ, et al. 18F-AV-1451 positron emission tomography in alzheimer\u2019s disease and progressive supranuclear palsy. Brain. 2017;140:781\u201391. https:\/\/doi.org\/10.1093\/brain\/aww340.","journal-title":"Brain"},{"key":"7539_CR29","unstructured":"Liaw A. Classification and regression by randomForest. R news. 2002."},{"key":"7539_CR30","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1023\/a:1016409317640","volume":"26","author":"V Podgorelec","year":"2002","unstructured":"Podgorelec V, Kokol P, Stiglic B, Rozman I. Decision trees: an overview and their use in medicine. J Med Syst. 2002;26:445\u201363. https:\/\/doi.org\/10.1023\/a:1016409317640.","journal-title":"J Med Syst"},{"key":"7539_CR31","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1198\/106186006X133933","volume":"15","author":"T Hothorn","year":"2006","unstructured":"Hothorn T, Hornik K, Zeileis A. Unbiased recursive partitioning: a conditional inference framework. J Comput Graph Stat. 2006;15:651\u201374. https:\/\/doi.org\/10.1198\/106186006X133933.","journal-title":"J Comput Graph Stat"},{"key":"7539_CR32","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","volume":"7","author":"MS Albert","year":"2011","unstructured":"Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7:270\u20139. https:\/\/doi.org\/10.1016\/j.jalz.2011.03.008.","journal-title":"Alzheimers Dement"},{"key":"7539_CR33","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr.","year":"2018","unstructured":"Jack CR Jr., Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, et al. NIA-AA research framework: toward a biological definition of alzheimer\u2019s disease. Alzheimers Dement. 2018;14:535\u201362. https:\/\/doi.org\/10.1016\/j.jalz.2018.02.018.","journal-title":"Alzheimers Dement"},{"key":"7539_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2023.1148054","volume":"17","author":"HC Lin","year":"2023","unstructured":"Lin HC, Lin KJ, Huang KL, Chen SH, Ho TY, Huang CC, et al. Visual reading for [(18)F]Florzolotau ([(18)F]APN-1607) tau PET imaging in clinical assessment of Alzheimer\u2019s disease. Front Neurosci. 2023;17: 1148054. https:\/\/doi.org\/10.3389\/fnins.2023.1148054.","journal-title":"Front Neurosci"},{"key":"7539_CR35","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1007\/s00259-013-2350-x","volume":"40","author":"IT Hsiao","year":"2013","unstructured":"Hsiao IT, Huang CC, Hsieh CJ, Wey SP, Kung MP, Yen TC, et al. Perfusion-like template and standardized normalization-based brain image analysis using 18F-florbetapir (AV-45\/Amyvid) PET. Eur J Nucl Med Mol Imaging. 2013;40:908\u201320. https:\/\/doi.org\/10.1007\/s00259-013-2350-x.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7539_CR36","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.neuroimage.2009.01.057","volume":"46","author":"A Joshi","year":"2009","unstructured":"Joshi A, Koeppe RA, Fessler JA. Reducing between scanner differences in multi-center PET studies. Neuroimage. 2009;46:154\u20139. https:\/\/doi.org\/10.1016\/j.neuroimage.2009.01.057.","journal-title":"Neuroimage"},{"key":"7539_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s40658-016-0159-y","volume":"3","author":"Y Ikari","year":"2016","unstructured":"Ikari Y, Akamatsu G, Nishio T, Ishii K, Ito K, Iwatsubo T, et al. Phantom criteria for qualification of brain FDG and amyloid PET across different cameras. EJNMMI Phys. 2016;3: 23. https:\/\/doi.org\/10.1186\/s40658-016-0159-y.","journal-title":"EJNMMI Phys"},{"key":"7539_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/dad2.12133","volume":"12","author":"I Sonni","year":"2020","unstructured":"Sonni I, Lesman Segev OH, Baker SL, Iaccarino L, Korman D, Rabinovici GD, et al. Evaluation of a visual interpretation method for tau-PET with (18)F-flortaucipir. Alzheimer\u2019s & Dementia: Diagnosis, Assessment & Disease Monitoring. 2020;12: e12133. https:\/\/doi.org\/10.1002\/dad2.12133.","journal-title":"Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring"},{"key":"7539_CR39","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1007\/s00259-024-06923-3","volume":"52","author":"FT Liu","year":"2025","unstructured":"Liu FT, Lu JY, Li XY, Ge JJ, Sun YM, Yen TC, et al. Visual reading for [(18)F]Florzolotau Tau PET scans in progressive supranuclear palsy. Eur J Nucl Med Mol Imaging. 2025;52:586\u201398. https:\/\/doi.org\/10.1007\/s00259-024-06923-3.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7539_CR40","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1097\/RLU.0000000000005141","volume":"49","author":"JL Hsu","year":"2024","unstructured":"Hsu JL, Wei YC, Hsiao IT, Lin KJ, Yen TC, Lu CS, et al. Dominance of tau burden in cortical over subcortical regions mediates glymphatic activity and clinical severity in PSP. Clin Nucl Med. 2024;49:387\u201396. https:\/\/doi.org\/10.1097\/RLU.0000000000005141.","journal-title":"Clin Nucl Med"},{"key":"7539_CR41","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1080\/01621459.1963.10500855","volume":"58","author":"JN Morgan","year":"1963","unstructured":"Morgan JN, Sonquist JA. Problems in the analysis of survey data, and a proposal. J Am Stat Assoc. 1963;58:415\u201334.","journal-title":"J Am Stat Assoc"},{"key":"7539_CR42","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1055\/s-0038-1634905","volume":"32","author":"DP McKenzie","year":"1993","unstructured":"McKenzie DP, McGorry PD, Wallace CS, Low LH, Copolov DL, Singh BS. Constructing a minimal diagnostic decision tree. Methods Inf Med. 1993;32:161\u20136.","journal-title":"Methods Inf Med"},{"key":"7539_CR43","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.arr.2017.03.002","volume":"36","author":"B Hall","year":"2017","unstructured":"Hall B, Mak E, Cervenka S, Aigbirhio FI, Rowe JB, O\u2019Brien JT. In vivo Tau PET imaging in dementia: pathophysiology, radiotracer quantification, and a systematic review of clinical findings. Ageing Res Rev. 2017;36:50\u201363. https:\/\/doi.org\/10.1016\/j.arr.2017.03.002.","journal-title":"Ageing Res Rev"},{"key":"7539_CR44","doi-asserted-by":"publisher","first-page":"73","DOI":"10.24095\/hpcdp.43.2.03","volume":"43","author":"K Battista","year":"2023","unstructured":"Battista K, Diao L, Patte KA, Dubin JA, Leatherdale ST. Examining the use of decision trees in population health surveillance research: an application to youth mental health survey data in the COMPASS study. Health Promot Chronic Dis Prev Can. 2023;43:73\u201386. https:\/\/doi.org\/10.24095\/hpcdp.43.2.03.","journal-title":"Health Promot Chronic Dis Prev Can"},{"key":"7539_CR45","doi-asserted-by":"publisher","first-page":"e0301541","DOI":"10.1371\/journal.pone.0301541","volume":"19","author":"S Uddin","year":"2024","unstructured":"Uddin S, Lu H. Confirming the statistically significant superiority of tree-based machine learning algorithms over their counterparts for tabular data. PLoS ONE. 2024;19:e0301541.","journal-title":"PLoS ONE"},{"key":"7539_CR46","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jcm.2016.02.012","volume":"15","author":"TK Koo","year":"2016","unstructured":"Koo TK, Li MY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med. 2016;15:155\u201363. https:\/\/doi.org\/10.1016\/j.jcm.2016.02.012.","journal-title":"J Chiropr Med"},{"key":"7539_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2014.07.003","volume":"11","author":"WE Klunk","year":"2015","unstructured":"Klunk WE, Koeppe RA, Price JC, Benzinger TL, Devous MD Sr., Jagust WJ, et al. The centiloid project: standardizing quantitative amyloid plaque estimation by PET. Alzheimers Dement. 2015;11:1-e151. https:\/\/doi.org\/10.1016\/j.jalz.2014.07.003.","journal-title":"Alzheimers Dement"},{"key":"7539_CR48","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-075800","volume":"13","author":"TP Leahy","year":"2023","unstructured":"Leahy TP, Simpson A, Sammon C, Ballard C, Gsteiger S. Estimating the prevalence of diagnosed Alzheimer disease in England across deprivation groups using electronic health records: a clinical practice research datalink study. BMJ Open. 2023;13: e075800. https:\/\/doi.org\/10.1136\/bmjopen-2023-075800.","journal-title":"BMJ Open"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07539-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-025-07539-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07539-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T04:43:21Z","timestamp":1769834601000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-025-07539-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["7539"],"URL":"https:\/\/doi.org\/10.1007\/s00259-025-07539-x","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,1]]},"assertion":[{"value":"12 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol complied with the tenets of the Declaration of Helsinki and was approved by the Institutional Review Board of the Chang Gung Memorial Hospital (no: 201800984A0, 201901949A0 and 201901999A0).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All patients provided written informed consent to participate in this prospective study. All data were securely protected by delinking identifying information from the main datasets. Access to the data was restricted exclusively to investigators, and all analyses were conducted anonymously.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Written informed consent was obtained from all participants or legal guardians. Patients signed informed consent regarding publishing their data and photographs.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}